Proton pump inhibitors (PPIs) are commonly prescribed in Australia. While they have an important role in the treatment of a number of conditions, they are often continued long-term unnecessarily. Over recent years there have been a number of studies flagging potential risks of their long-term use.
This KISS explores the limited indications for long-term PPI prescription, potential safety concerns and when dose reduction or cessation may be more appropriate. Download the KISS summary here.
These KISS summaries are a taster of the NB Medical / Medcast Hot Topics workshop series. The live workshop series for 2018 is complete and we are busy planning the 2019 events.
However, you may be interested in our online course where you can watch video recordings of the presentations, and access the online workbook and KISS summaries. Read more about the online course here.
Chandelle is a GP and Medical Educator on the Central Coast of NSW.
Become a member and get unlimited access to 100s of hours of premium education.
Learn moreAnthony is a retired engineer, who is compliant with his COPD and diabetes management but has been struggling with frequent exacerbations of his COPD.
Whilst no longer considered a public health emergency, the significant, long-term impacts of Covid-19 continue to be felt with children’s mental health arguably one of the great impacts of the pandemic.
Your next patient is Frankie, a 5 year old girl, who is brought in by her mother Nora. Frankie has been unwell for the past 48 hours with fever, sore throat and headache. The previous day Nora noticed a rash over Frankie’s neck and chest which has since spread over the rest of her body.